Literature DB >> 23112334

Regulatory T cells increase the avidity of primary CD8+ T cell responses and promote memory.

Luigia Pace1, Andy Tempez, Catharina Arnold-Schrauf, Fabrice Lemaitre, Philippe Bousso, Luc Fetler, Tim Sparwasser, Sebastian Amigorena.   

Abstract

Although regulatory T cells (T(regs)) are known to suppress self-reactive autoimmune responses, their role during T cell responses to nonself antigens is not well understood. We show that T(regs) play a critical role during the priming of immune responses in mice. T(reg) depletion induced the activation and expansion of a population of low-avidity CD8(+) T cells because of overproduction of CCL-3/4/5 chemokines, which stabilized the interactions between antigen-presenting dendritic cells and low-avidity T cells. In the absence of T(regs), the avidity of the primary immune response was impaired, which resulted in reduced memory to Listeria monocytogenes. These results suggest that T(regs) are important regulators of the homeostasis of CD8(+) T cell priming and play a critical role in the induction of high-avidity primary responses and effective memory.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23112334     DOI: 10.1126/science.1227049

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  60 in total

Review 1.  Sizing up the key determinants of the CD8(+) T cell response.

Authors:  David C Tscharke; Nathan P Croft; Peter C Doherty; Nicole L La Gruta
Journal:  Nat Rev Immunol       Date:  2015-10-09       Impact factor: 53.106

2.  T cell avidity and tumor immunity: problems and solutions.

Authors:  Arthur A Hurwitz; Steven M Cuss; Katherine E Stagliano; Ziqiang Zhu
Journal:  Cancer Microenviron       Date:  2013-12-20

3.  Distinct temporal patterns of T cell receptor signaling during positive versus negative selection in situ.

Authors:  Heather J Melichar; Jenny O Ross; Paul Herzmark; Kristin A Hogquist; Ellen A Robey
Journal:  Sci Signal       Date:  2013-10-15       Impact factor: 8.192

Review 4.  The opposing roles of CD4+ T cells in anti-tumour immunity.

Authors:  Tomasz Ahrends; Jannie Borst
Journal:  Immunology       Date:  2018-04-27       Impact factor: 7.397

5.  T Cells Integrate Local and Global Cues to Discriminate between Structurally Similar Antigens.

Authors:  Guillaume Voisinne; Briana G Nixon; Anna Melbinger; Georg Gasteiger; Massimo Vergassola; Grégoire Altan-Bonnet
Journal:  Cell Rep       Date:  2015-05-26       Impact factor: 9.423

6.  IL-2 Modulates the TCR Signaling Threshold for CD8 but Not CD4 T Cell Proliferation on a Single-Cell Level.

Authors:  Byron B Au-Yeung; Geoffrey Alexander Smith; James L Mueller; Cheryl S Heyn; Rebecca Garrett Jaszczak; Arthur Weiss; Julie Zikherman
Journal:  J Immunol       Date:  2017-02-03       Impact factor: 5.422

Review 7.  Chemokine-guided cell positioning in the lymph node orchestrates the generation of adaptive immune responses.

Authors:  Jeffrey Lian; Andrew D Luster
Journal:  Curr Opin Cell Biol       Date:  2015-06-08       Impact factor: 8.382

8.  Activation of GILZ gene by photoactivated 8-methoxypsoralen: potential role of immunoregulatory dendritic cells in extracorporeal photochemotherapy.

Authors:  Jeffrey S Futterleib; Hao Feng; Robert E Tigelaar; Jaehyuk Choi; Richard L Edelson
Journal:  Transfus Apher Sci       Date:  2013-10-24       Impact factor: 1.764

Review 9.  The Immune Fulcrum: Regulatory T Cells Tip the Balance Between Pro- and Anti-inflammatory Outcomes upon Infection.

Authors:  Laura E Richert-Spuhler; Jennifer M Lund
Journal:  Prog Mol Biol Transl Sci       Date:  2015-08-18       Impact factor: 3.622

10.  Human regulatory T cells kill tumor cells through granzyme-dependent cytotoxicity upon retargeting with a bispecific antibody.

Authors:  Bryan D Choi; Patrick C Gedeon; James E Herndon; Gary E Archer; Elizabeth A Reap; Luis Sanchez-Perez; Duane A Mitchell; Darell D Bigner; John H Sampson
Journal:  Cancer Immunol Res       Date:  2013-09       Impact factor: 11.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.